{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:56:54Z","timestamp":1781618214257,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T00:00:00Z","timestamp":1743638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971644,81671720,81471688"],"award-info":[{"award-number":["81971644,81671720,81471688"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00259-025-07197-z","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T13:46:26Z","timestamp":1743774386000},"page":"3891-3902","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exendin-4 imaging based on gastrointestinal GLP-1R targets for IBD diagnosis and efficacy assessment"],"prefix":"10.1007","volume":"52","author":[{"given":"Xiaochen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zizhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangxi","family":"Hai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6488-6232","authenticated-orcid":false,"given":"Yifan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"7197_CR1","doi-asserted-by":"crossref","unstructured":"Kilby K, Mathias H, Boisvenue L et al. Micronutrient Absorption and Related Outcomes in People with Inflammatory Bowel Disease: A Review. Nutrients.2019;11.","DOI":"10.3390\/nu11061388"},{"key":"7197_CR2","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1210\/en.2008-0726","volume":"150","author":"GE Lim","year":"2009","unstructured":"Lim GE, Huang GJ, Flora N, et al. Insulin regulates Glucagon-Like Peptide-1 secretion from the enteroendocrine L cell. Endocrinology. 2009;150:580\u201391.","journal-title":"Endocrinology"},{"key":"7197_CR3","doi-asserted-by":"crossref","unstructured":"Lee Y-S, Jun H-S. Anti-Inflammatory effects of GLP-1-Based therapies beyond glucose control. Mediators Inflamm.2016;2016.","DOI":"10.1155\/2016\/3094642"},{"key":"7197_CR4","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1136\/gutjnl-2012-303280","volume":"62","author":"H Kissow","year":"2013","unstructured":"Kissow H, Hartmann B, Holst JJ, et al. Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis. Gut. 2013;62:1724\u201333.","journal-title":"Gut"},{"key":"7197_CR5","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.2337\/db14-1577","volume":"64","author":"B Yusta","year":"2015","unstructured":"Yusta B, Baggio LL, Koehler J, et al. GLP-1R agonists modulate enteric immune responses through the intestinal intraepithelial lymphocyte GLP-1R. Diabetes. 2015;64:2537\u201349.","journal-title":"Diabetes"},{"key":"7197_CR6","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1097\/MIB.0000000000000847","volume":"22","author":"CH Bang-Berthelsen","year":"2016","unstructured":"Bang-Berthelsen CH, Holm TL, Pyke C, et al. GLP-1 induces barrier protective expression in Brunner\u2019s glands and regulates colonic inflammation. Inflamm Bowel Dis. 2016;22:2078\u201397.","journal-title":"Inflamm Bowel Dis"},{"key":"7197_CR7","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.2967\/jnumed.115.157768","volume":"56","author":"K Antwi","year":"2015","unstructured":"Antwi K, Fani M, Nicolas G, et al. Localization of hidden insulinomas with \u2076\u2078Ga-DOTA-Exendin-4 PET\/CT: A pilot study. J Nucl Med. 2015;56:1075\u20138.","journal-title":"J Nucl Med"},{"key":"7197_CR8","doi-asserted-by":"publisher","first-page":"717101","DOI":"10.3389\/fendo.2021.717101","volume":"12","author":"H Fujimoto","year":"2021","unstructured":"Fujimoto H, Fujita N, Hamamatsu K, et al. First-in-Human evaluation of positron emission tomography\/computed tomography with [(18)F]FB(ePEG12)12-Exendin-4: A phase 1 clinical study targeting GLP-1 receptor expression cells in pancreas. Front Endocrinol (Lausanne). 2021;12:717101.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7197_CR9","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s00253-018-9562-8","volume":"103","author":"Y Pan","year":"2019","unstructured":"Pan Y, Lv J, Pan D, et al. Evaluating the utility of human glucagon-like peptide 1 receptor gene as a novel radionuclide reporter gene: a promising molecular imaging tool. Appl Microbiol Biotechnol. 2019;103:1311\u201324.","journal-title":"Appl Microbiol Biotechnol"},{"key":"7197_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1046\/j.1365-2249.2000.01183.x","volume":"120","author":"M Murano","year":"2000","unstructured":"Murano M, Maemura K, Hirata I, et al. Therapeutic effect of intracolonically administered nuclear factor \u039aB (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis. Clin Exp Immunol. 2000;120:51\u20138.","journal-title":"Clin Exp Immunol"},{"key":"7197_CR11","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/ibd.21801","volume":"18","author":"J Adler","year":"2012","unstructured":"Adler J, Punglia DR, Dillman JR, et al. Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn\u2019s disease. Inflamm Bowel Dis. 2012;18:849\u201356.","journal-title":"Inflamm Bowel Dis"},{"key":"7197_CR12","doi-asserted-by":"publisher","first-page":"748","DOI":"10.2967\/jnumed.112.112623","volume":"54","author":"D Bettenworth","year":"2013","unstructured":"Bettenworth D, Reuter S, Hermann S, et al. Translational 18F-FDG PET\/CT imaging to monitor lesion activity in intestinal inflammation. J Nucl Med. 2013;54:748\u201355.","journal-title":"J Nucl Med"},{"key":"7197_CR13","doi-asserted-by":"crossref","unstructured":"Luo Y, Yu M, Pan Q, et al. 68Ga-NOTA-exendin-4 PET\/CT in detection of occult Insulinoma and evaluation of physiological uptake. Eur J Nucl Med Mol Imaging. 2015;42:531\u20132.","DOI":"10.1007\/s00259-014-2946-9"},{"key":"7197_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.nucmedbio.2019.08.002","volume":"74\u201375","author":"P Zhang","year":"2019","unstructured":"Zhang P, Zhao Z, Zhang L, et al. 68Ga-NOTA-MAL-Cys39-exendin-4, a potential GLP-1R targeted PET tracer for the detection of Insulinoma. Nucl Med Biol. 2019;74\u201375:19\u201324.","journal-title":"Nucl Med Biol"},{"key":"7197_CR15","doi-asserted-by":"crossref","unstructured":"Pyke C, Heller RS, Kirk RK, et al. GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody. Endocrinology. 2014;155:1280\u201390.","DOI":"10.1210\/en.2013-1934"},{"key":"7197_CR16","doi-asserted-by":"crossref","unstructured":"Andersen DB, Grunddal KV, Pedersen J et al. Using a Reporter Mouse to Map Known and Novel Sites of GLP-1 Receptor Expression in Peripheral Tissues of Male Mice. Endocrinology.2021;162.","DOI":"10.1210\/endocr\/bqaa246"},{"key":"7197_CR17","doi-asserted-by":"crossref","unstructured":"Manell E, Puuvuori E, Svensson A et al. Exploring the GLP-1-GLP-1R axis in Porcine pancreas and Gastrointestinal tract in vivo by ex vivo autoradiography. BMJ Open Diabetes Res Care.2021;9.","DOI":"10.1136\/bmjdrc-2020-002083"},{"key":"7197_CR18","doi-asserted-by":"crossref","unstructured":"Grunddal KV, Jensen EP, Orskov C et al. Expression Profile of the GLP-1 Receptor in the Gastrointestinal Tract and Pancreas in Adult Female Mice. Endocrinology.2022;163.","DOI":"10.1210\/endocr\/bqab216"},{"key":"7197_CR19","doi-asserted-by":"crossref","unstructured":"Anand U, Yiangou Y, Akbar A et al. Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons. PLoS ONE.2018;13.","DOI":"10.1371\/journal.pone.0198024"},{"key":"7197_CR20","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1007\/s43440-021-00327-y","volume":"73","author":"H Zatorski","year":"2021","unstructured":"Zatorski H, Salaga M, Zielinska M, et al. Colonic inflammation induces changes in glucose levels through modulation of incretin system. Pharmacol Rep. 2021;73:1670\u20139.","journal-title":"Pharmacol Rep"},{"key":"7197_CR21","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/bph.15611","volume":"179","author":"JJ Holst","year":"2022","unstructured":"Holst JJ, Andersen DB, Grunddal KV. Actions of glucagon-like peptide-1 receptor ligands in the gut. Br J Pharmacol. 2022;179:727\u201342.","journal-title":"Br J Pharmacol"},{"key":"7197_CR22","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.cmet.2022.08.003","volume":"34","author":"CK Wong","year":"2022","unstructured":"Wong CK, Yusta B, Koehler JA, et al. Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota, and T cell-induced inflammation. Cell Metab. 2022;34:1514\u201331.","journal-title":"Cell Metab"},{"key":"7197_CR23","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nri3661","volume":"14","author":"MF Neurath","year":"2014","unstructured":"Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14:329\u201342.","journal-title":"Nat Rev Immunol"},{"key":"7197_CR24","doi-asserted-by":"crossref","unstructured":"Hong D, Kim HK, Yang W et al. Integrative analysis of single-cell RNA-seq and gut Microbiome metabarcoding data elucidates macrophage dysfunction in mice with DSS-induced ulcerative colitis. Commun Biol.2024;7.","DOI":"10.1038\/s42003-024-06409-w"},{"key":"7197_CR25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375:311\u201322.","journal-title":"N Engl J Med"},{"key":"7197_CR26","doi-asserted-by":"crossref","unstructured":"Villumsen M, Schelde AB, Jimenez-Solem E et al. GLP-1 based therapies and disease course of inflammatory bowel disease. EClinicalMedicine.2021;37.","DOI":"10.1016\/j.eclinm.2021.100979"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07197-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07197-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07197-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T09:12:20Z","timestamp":1757149940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07197-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,3]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["7197"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07197-z","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,3]]},"assertion":[{"value":"31 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Animal Ethics Committee of Ruijin Hospital, Shanghai JiaoTong University School of Medicine (No. RJ2023028). This study was obtained from the Ruijin Hospital Ethics Committee, Shanghai Jiao Tong University School of Medicine, with the approval number: (2020) Ethical Review No.(52).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors of the current manuscript meet the specified criteria for authorship and agreed to publish this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}